Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC (HAMLET)
Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage Non-small Cell Lung Cancer HAMLET Study
Sponsor: Erasmus Medical Center
Listed as NCT02488850, this NA trial focuses on Non-small Cell Lung Cancer and remains completed. Sponsored by Erasmus Medical Center, it has been updated 8 times since 2012, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Dec 2024 — Present [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Mar 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Jan 2021 — Mar 2023 [monthly]
Unknown Status NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Aug 2017 — Jun 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Dec 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Erasmus Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .